Clin2
NCT05748015Possibly a fitRecruiting

Checking how the nervous system is affected in multiple sclerosis

Multiple Sclerosis

Part of Brain & nervous system, Immune system & allergy clinical trials.

This study looks at signs of how your automatic “control” nerves (the autonomic nervous system) may be affected in people with multiple sclerosis. It may help researchers better understand different types of MS and how to recognize nervous-system involvement.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have been diagnosed with multiple sclerosis (MS) and your type is either relapsing-remitting or primary progressive.
  • Your MS is not a different MS type than those listed.
  • You do not have another known neurological condition besides MS.
  • You are not taking any drugs or substances that could harm the nervous system (neurotoxic substances).
  • You can follow the study’s planned testing/assessment to measure nervous-system involvement.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07012135Recruiting
Autonomic Function in Multiple Sclerosis

This study looks at how the nervous system controls automatic body functions (like heart rate and blood pressure) in people with multiple sclerosis. Researchers want to compare results between people with MS and healthy volunteers to understand how MS affects these functions.

Rochester, Minnesota
NCT07723599Not yet recruiting
Fighting age-related nerve damage in multiple sclerosis

This study tests if a treatment can help repair age-related damage to the protective coating around nerves in people with multiple sclerosis. It may help improve nerve function and slow disability.

Seattle, Washington
NCT04604041Recruiting
Study early warning signs in relapsing-remitting multiple sclerosis

This study looks at “subclinical markers,” meaning early or hidden body changes that may show how relapsing-remitting multiple sclerosis (MS) is doing even when symptoms seem mild. It may help researchers find better ways to monitor MS and detect changes sooner.

Split
NCT06432686Not yet recruiting
TENS for nerve symptoms in multiple sclerosis

This trial tests if a mild, noninvasive nerve stimulation device (TENS) can improve symptoms like pain or muscle tightness in people with multiple sclerosis. It looks at how the treatment affects your nerves and daily function.

NCT03981003Recruiting
Blood tests to track brain and nerve changes in MS

This study measures blood markers (from a serum blood sample) to see how nerve and brain changes relate to MS disease activity and disability over time. It may help researchers better monitor MS, especially in people followed in the OFSEP program.

Amiens
NCT07333196Not yet recruiting
Long-term study of brain and nerve diseases

This observational study follows people with various immune-related neurological conditions, such as multiple sclerosis, neuromyelitis optica, and autoimmune encephalitis. It aims to better understand these diseases and their progression over time.

Wuhan, Hubei

Hear when a new Multiple sclerosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.